IE
RYTM icon

Israel Englander’s Rhythm Pharmaceuticals RYTM Stock Holding History

Israel Englander’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,000
Closed -$632K – 6407
2025
Q2 		$632K Sell
10,000
-5,000
-33% -$306K ﹤0.01% 4734
2025
Q1 		$795K Buy
+15,000
New +$832K ﹤0.01% 4519
2023
Q4 		– Sell
-35,200
Closed -$807K – 6474
2023
Q3 		$807K Buy
+35,200
New +$788K ﹤0.01% 4337

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Israel Englander's RYTM Position: Q2 2026 in Review

Israel Englander reduced its Rhythm Pharmaceuticals (RYTM) stake by 30% in Q2 2026, selling an estimated $12.2M and leaving 316,719 shares worth $35.2M. The position accounts for 0.01% of the portfolio, ranked #1148.

Israel Englander first reported a position in RYTM in Q2 2018 and has held it in 24 quarters since. The position peaked at $39.3M in Q1 2026. 300 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Israel Englander held 316,719 shares of Rhythm Pharmaceuticals worth $35.2M as of Q2 2026.
  • Israel Englander sold 135,106 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $12.2M.
  • Rhythm Pharmaceuticals made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1148 holding.
  • Israel Englander first reported a position in Rhythm Pharmaceuticals in Q2 2018 and has held it in 24 quarters since.
  • Israel Englander's Rhythm Pharmaceuticals position peaked at $39.3M in Q1 2026.
  • 300 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.